Sign in
4

Changes in Ownership

SELLAS Life Sciences Group, Inc. Filed Acc 0001250853-14-000043

Director sold 300,000 shares at $4.18 ($1,253,040)

  • Director acquired 300,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
GALLIKER STEPHEN S Director 2014-02-03 Option exercise +50,000 $2.31 $115,500 60,000 D
GALLIKER STEPHEN S Director 2014-02-03 Option exercise +100,000 $1.18 $118,000 160,000 D
GALLIKER STEPHEN S Director 2014-02-03 Option exercise +50,000 $0.85 $42,500 210,000 D
GALLIKER STEPHEN S Director 2014-02-03 Option exercise +50,000 $0.72 $36,000 260,000 D
GALLIKER STEPHEN S Director 2014-02-03 Option exercise +50,000 $1.71 $85,500 310,000 D
GALLIKER STEPHEN S Director 2014-02-03 Sale −300,000 $4.18 $1,253,040 10,000 D
Derivatives
GALLIKER STEPHEN S Director 2014-02-03 Option exercise · Stock Option (right to buy) −50,000 0 D
GALLIKER STEPHEN S Director 2014-02-03 Option exercise · Stock Option (right to buy) −100,000 0 D
GALLIKER STEPHEN S Director 2014-02-03 Option exercise · Stock Option (right to buy) −50,000 0 D
GALLIKER STEPHEN S Director 2014-02-03 Option exercise · Stock Option (right to buy) −50,000 0 D
GALLIKER STEPHEN S Director 2014-02-03 Option exercise · Stock Option (right to buy) −50,000 0 D
Open-market sales · 300,000 sh · avg $4.18 · $1,253,040
Loading xslF345X03/primary_doc.xml…